{"id":"NCT01539317","sponsor":"OHSU Knight Cancer Institute","briefTitle":"Therapy to Prevent Sexual Pain in Breast Cancer Survivors","officialTitle":"Therapy to Prevent Sexual Pain in Menopausal Survivors of Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12","primaryCompletion":"2013-11","completion":"2013-11","firstPosted":"2012-02-27","resultsPosted":"2015-08-04","lastUpdate":"2017-04-14"},"enrollment":50,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Vulvodynia","Dyspareunia","Breast Cancer","Menopause"],"interventions":[{"type":"DRUG","name":"Topical liquid lidocaine","otherNames":[]},{"type":"DRUG","name":"Topical saline","otherNames":["water"]}],"arms":[{"label":"Topical liquid lidocaine","type":"ACTIVE_COMPARATOR"},{"label":"Topical Saline","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this protocol is to determine whether pain with sexual intercourse can be reduced in menopausal, breast cancer survivors and to evaluate the effectiveness of a non-hormonal therapy (Lidocaine Liquid) vs. a placebo liquid in reducing pain.\n\nThe investigators hypothesize that the pain arises in the vulvar vestibule. The investigators predict that the localized use of lidocaine will be more efficacious than use of placebo liquid.","primaryOutcome":{"measure":"Prevention of Entry Dyspareunia With Non-hormonal Therapy","timeFrame":"During Phase II (0-4 weeks) and during Phase III (5-12 weeks)","effectByArm":[{"arm":"Topical Saline","deltaMin":5.3,"sd":null},{"arm":"Topical Liquid Lidocaine","deltaMin":1.04,"sd":null},{"arm":"Open Label","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0149"},{"comp":"OG000 vs OG001 vs OG002","p":"0.412"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["26215946","24807329"],"seeAlso":["http://www.ohsu.edu/xd/health/services/women/clinical-trials"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":[]}}